Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Grifols ADR Representing One Non-Voting Ord Shs Class B GRFS

Healthcare Biotechnology

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale... see more

Add To Watchlist

Recent & Breaking News (NDAQ:GRFS)

Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions

PR Newswire Europe Non Regulatory January 8, 2019

30 Stocks Moving In Monday's Pre-Market Session

Benzinga.com October 29, 2018

Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol

PR Newswire Europe Non Regulatory October 27, 2018

FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

PR Newswire October 12, 2018

Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support

PR Newswire October 8, 2018

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com October 3, 2018

Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio

PR Newswire September 24, 2018

Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

PR Newswire August 16, 2018

Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System

PR Newswire August 14, 2018

Free Technical Research Reports on Biotech Stocks -- Epizyme, Esperion Therapeutics, Exelixis, and Grifols

PR Newswire July 27, 2018

Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays

PR Newswire June 19, 2018

Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. — New Research Emphasizes Economic Growth

GlobeNewswire June 7, 2018

Grifols Launches a New Testing Service for Patients Treated with Daratumumab

PR Newswire May 31, 2018

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

PR Newswire May 14, 2018

Grifols donates over 25 million international units of blood clotting factor in 2017

PR Newswire April 16, 2018

Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire April 10, 2018

Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018

PR Newswire April 6, 2018

Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V. — Fundamental Analysis, Key Performance Indications

GlobeNewswire March 13, 2018

Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.

PR Newswire March 5, 2018

Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD"

PR Newswire February 28, 2018